{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:54:00Z","timestamp":1790830440309,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NINDS","award":["P51OD011092"],"award-info":[{"award-number":["P51OD011092"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.nbd.2018.09.025","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:52:25Z","timestamp":1538711545000},"page":"214-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6\/2 mouse model of huntington's disease"],"prefix":"10.1016","volume":"121","author":[{"given":"Brett D.","family":"Dufour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4816-7569","authenticated-orcid":false,"given":"Jodi L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.09.025_bb0005","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-13-0471","article-title":"Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study","volume":"169","author":"Andela","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0010","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11920-996-0030-2","article-title":"An overview of psychiatric symptoms in Huntington's disease","volume":"3","author":"Anderson","year":"2001","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.nbd.2018.09.025_bb0015","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.09.025_bb0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","article-title":"Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease","volume":"94","author":"Aziz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2018.09.025_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2012.12.003","article-title":"Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology","volume":"74","author":"Baglietto-Vargas","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.025_bb0030","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1212\/WNL.45.10.1867","article-title":"A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates","volume":"45","author":"Bamford","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.09.025_bb0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The R6\/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"Bjorkqvist","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0040","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0045","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington's disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0050","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00000658-198210000-00005","article-title":"Mechanisms of insulin resistance following injury","volume":"196","author":"Black","year":"1982","journal-title":"Ann. Surg."},{"key":"10.1016\/j.nbd.2018.09.025_bb0055","first-page":"1949","article-title":"Loss of brain volume in endogenous cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2018.09.025_bb0060","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1096\/fj.13-230375","article-title":"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle","volume":"27","author":"Braun","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2018.09.025_bb0065","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neuroscience.2010.04.023","article-title":"Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats","volume":"168","author":"Brummelte","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.09.025_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0039-128X(91)90124-E","article-title":"Autoregulation of glucocorticoid receptor gene expression","volume":"56","author":"Burnstein","year":"1991","journal-title":"Steroids"},{"key":"10.1016\/j.nbd.2018.09.025_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0306-4522(94)90224-0","article-title":"Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus","volume":"61","author":"Cameron","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.09.025_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.mp.4001679","article-title":"Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation","volume":"10","author":"Crochemore","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.025_bb0085","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1152\/jn.00762.2011","article-title":"A critical window of CAG repeat-length correlates with phenotype severity in the R6\/2 mouse model of Huntington's disease","volume":"107","author":"Cummings","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington's disease","volume":"8","author":"van der Burg","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2018.09.025_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","article-title":"Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice","volume":"44","author":"van der Burg","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.97.2.657","article-title":"Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor","volume":"97","author":"Diamond","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.09.025_bb0110","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.09.025_bb0115","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/tp.2012.58","article-title":"Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease","volume":"2","author":"Du","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.025_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2014.09.009","article-title":"The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease","volume":"263","author":"Du","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2016.06.028","article-title":"Corticosterone dysregulation exacerbates disease progression in the R6\/2 transgenic mouse model of Huntington's disease","volume":"283","author":"Dufour","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainresbull.2010.08.006","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington's disease mutation carriers compared with mutation-negative first-degree controls","volume":"83","author":"van Duijn","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2018.09.025_bb0135","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2018.09.025_bb0140","first-page":"628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0145","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ajcn\/81.6.1335","article-title":"Energy balance in early-stage Huntington disease","volume":"81","author":"Gaba","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.nbd.2018.09.025_bb0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.09.025_bb0155","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","article-title":"Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington's disease mice","volume":"20","author":"Gil","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0160","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","article-title":"The metabolic profile of early Huntington's disease\u2013a combined human and transgenic mouse study","volume":"210","author":"Goodman","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0165","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1523\/JNEUROSCI.12-09-03642.1992","article-title":"Adrenal hormones suppress cell division in the adult rat dentate gyrus","volume":"12","author":"Gould","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0170","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0175","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.nbd.2018.09.025_bb0180","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/cells2020202","article-title":"Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword","volume":"2","author":"Gruver-Yates","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.09.025_bb0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00075197-200405000-00006","article-title":"Testosterone action on skeletal muscle","volume":"7","author":"Herbst","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"10.1016\/j.nbd.2018.09.025_bb0195","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","article-title":"The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease","volume":"30","author":"Heuser","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.09.025_bb0200","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0205","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's disease collaborative research group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.09.025_bb0210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's disease rating scale: reliability and consistency. Huntington study group","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.09.025_bb0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0270(02)00007-9","article-title":"The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis","volume":"115","author":"Kee","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2018.09.025_bb0220","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0225","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/mds.21550","article-title":"Myopathy as a first symptom of Huntington's disease in a Marathon runner","volume":"22","author":"Kosinski","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.09.025_bb0230","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease","volume":"121","author":"Labbadia","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2018.09.025_bb0235","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00001756-200404090-00014","article-title":"Decreased hippocampal cell proliferation in R6\/1 Huntington's mice","volume":"15","author":"Lazic","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2018.09.025_bb0240","doi-asserted-by":"crossref","first-page":"1806S","DOI":"10.1093\/jn\/135.7.1806S","article-title":"Apoptosis of skeletal muscle on steroid-induced myopathy in rats","volume":"135","author":"Lee","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.nbd.2018.09.025_bb0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"Lofberg","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.nbd.2018.09.025_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0306-4522(03)00421-4","article-title":"Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-d-aspartate receptors","volume":"121","author":"Lu","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2018.09.025_bb0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/271","article-title":"Cortisol levels during human aging predict hippocampal atrophy and memory deficits","volume":"1","author":"Lupien","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0260","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JHD-130075","article-title":"Skeletal muscle atrophy in R6\/2 mice - altered circulating skeletal muscle markers and gene expression profile changes","volume":"3","author":"Magnusson-Lind","year":"2014","journal-title":"J. Huntingtons. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0270","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/hmg\/ddt667","article-title":"Dexamethasone induces heat shock response and slows down disease progression in mouse and fly models of Huntington's disease","volume":"23","author":"Maheshwari","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.09.025_bb0275","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.neuro.22.1.105","article-title":"Stress and hippocampal plasticity","volume":"22","author":"McEwen","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2013.07.041","article-title":"Short-term memory acquisition in female Huntington's disease mice is vulnerable to acute stress","volume":"253","author":"Mo","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2018.09.025_bb0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nbd.2014.05.004","article-title":"High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice","volume":"69","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2014.07.008","article-title":"Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice","volume":"71","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0295","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2014.07.044","article-title":"Ethological endophenotypes are altered by elevated stress hormone levels in both Huntington's disease and wildtype mice","volume":"274","author":"Mo","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2018.09.025_bb0300","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease","volume":"4","author":"Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.09.025_bb0305","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.1202","article-title":"Mifepristone for management of Cushing's syndrome","volume":"33","author":"Morgan","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.nbd.2018.09.025_bb0310","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molmed.2012.04.005","article-title":"Glucocorticoid receptor signaling in bone cells","volume":"18","author":"Moutsatsou","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2018.09.025_bb0315","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.09.025_bb0320","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1460-9568.2005.04324.x","article-title":"Reduction of GnRH and infertility in the R6\/2 mouse model of Huntington's disease","volume":"22","author":"Papalexi","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0325","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1460-9568.2006.04985.x","article-title":"Hypothalamic-endocrine aspects in Huntington's disease","volume":"24","author":"Petersen","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0330","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1531-8249(200001)47:1<64::AID-ANA11>3.0.CO;2-S","article-title":"Higher sedentary energy expenditure in patients with Huntington's disease","volume":"47","author":"Pratley","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0340","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0345","first-page":"1","article-title":"The Neuropathology of Huntington s disease: classical findings, recent developments and correlation to functional neuroanatomy","volume":"217","author":"Rub","year":"2015","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0350","doi-asserted-by":"crossref","first-page":"e4962","DOI":"10.1371\/journal.pone.0004962","article-title":"Neuroendocrine disturbances in Huntington's disease","volume":"4","author":"Saleh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.09.025_bb0355","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1523\/JNEUROSCI.05-05-01222.1985","article-title":"Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging","volume":"5","author":"Sapolsky","year":"1985","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0360","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1523\/JNEUROSCI.10-09-02897.1990","article-title":"Hippocampal damage associated with prolonged glucocorticoid exposure in primates","volume":"10","author":"Sapolsky","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000072864","article-title":"Mechanisms of neuronal cell death in Huntington's disease","volume":"100","author":"Sawa","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.nbd.2018.09.025_bb0375","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.1152\/ajpendo.00630.2010","article-title":"Molecular characterization of skeletal muscle atrophy in the R6\/2 mouse model of Huntington's disease","volume":"301","author":"She","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.nbd.2018.09.025_bb0380","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-012-6732-y","article-title":"The relationship between cortisol and verbal memory in the early stages of Huntington's disease","volume":"260","author":"Shirbin","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0385","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington's disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2018.09.025_bb0390","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12189","article-title":"Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome","volume":"79","author":"Toth","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0400","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington's disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.1016\/j.nbd.2018.09.025_bb0405","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuint.2005.11.011","article-title":"17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats","volume":"48","author":"Tunez","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2018.09.025_bb0410","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.09.025_bb0415","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nbd.2007.01.006","article-title":"Testicular degeneration in Huntington disease","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.09.025_bb0420","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.09.025_bb0425","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/j.1460-9568.2004.03717.x","article-title":"The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus","volume":"20","author":"Wong","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.09.025_bb0430","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","article-title":"Increased thirst and drinking in Huntington's disease and the R6\/2 mouse","volume":"76","author":"Wood","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2018.09.025_bb0435","doi-asserted-by":"crossref","first-page":"e9077","DOI":"10.1371\/journal.pone.0009077","article-title":"Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease","volume":"5","author":"Wood","year":"2010","journal-title":"PLoS One"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118302031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118302031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T02:31:19Z","timestamp":1605148279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118302031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":87,"alternative-id":["S0969996118302031"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.09.025","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6\/2 mouse model of huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}